RecruitingPhase 3NCT07304284
Trial to Evaluate Immunogenicity Non-Inferiority, Safety and Lot-to-Lot Consistency of Biovac OCV-S to Euvichol®-Plus
Studying Cholera
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- International Vaccine Institute
- Principal Investigator
- Tarun Saluja, MDInternational Vaccine Institute
- Intervention
- Experimental: Biovac OCV-S (inactivated whole-cell monovalent (O1) oral cholera vaccine)(biological)
- Enrollment
- 2824 enrolled
- Eligibility
- 1-45 years · All sexes
- Timeline
- 2025 – 2027
Study locations (5)
- Synergy Biomed Research Institute, Durban, Eastern Cape, South Africa
- Perinatal HIV Research Unit (PHRU), Johannesburg, Gauteng, South Africa
- Wits Vaccines & Infectious Diseases Analytics (VIDA) Research Unit, Johannesburg, Gauteng, South Africa
- SAMRC Chatworth CRS, Durban, KwaZulu-Natal, South Africa
- SAMRC Isipingo CRS, Durban, KwaZulu-Natal, South Africa
Collaborators
BioVac · Medical Research Council, South Africa
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07304284 on ClinicalTrials.govOther trials for Cholera
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07509047Age-descending Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Adults and ChildrenInternational Vaccine Institute
- RECRUITINGPHASE4NCT07487077Extended Dosing Intervals Trial for Oral Cholera Vaccine, KenyaAlbert B. Sabin Vaccine Institute
- RECRUITINGNANCT06455852Vaccine- and Infection-derived Correlates of Protection for Cholera.Massachusetts General Hospital
- RECRUITINGNANCT06498817Testing a Scalable Model of the Cholera Hospital-Based Intervention for 7 Days (CHoBI7)Johns Hopkins Bloomberg School of Public Health
- RECRUITINGNANCT06003816Cholera-Hospital-Based-Intervention-for-7-Days (CHoBI7) Water, Sanitation, and Hygiene (WASH) Case Area Targeted Intervention (CATI)Johns Hopkins Bloomberg School of Public Health
- RECRUITINGNANCT05166850Preventative Intervention for Cholera for 7 DaysJohns Hopkins Bloomberg School of Public Health
- ACTIVE NOT RECRUITINGPHASE2NCT04326478Single Dose Azithromycin to Prevent Cholera in ChildrenMassachusetts General Hospital
- RECRUITINGNCT04853186Impact Study of Cholera Vaccination in Endemic Areas - Clinical SurveillanceEpicentre